Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Mar 14;22(1):201.
doi: 10.1186/s12884-022-04530-4.

Safety and efficacy of preoperative tranexamic acid in reducing intraoperative and postoperative blood loss in high-risk women undergoing cesarean delivery: a randomized controlled trial

Affiliations
Randomized Controlled Trial

Safety and efficacy of preoperative tranexamic acid in reducing intraoperative and postoperative blood loss in high-risk women undergoing cesarean delivery: a randomized controlled trial

Mohamed A Shalaby et al. BMC Pregnancy Childbirth. .

Erratum in

Abstract

Background: Objective to assess the value of preoperative tranexamic acid (TXA) in reduction of intraoperative and postoperative blood loss in high-risk cesarean delivery (CD).

Methods: A double blind randomized controlled trial included 160 high risk women who underwent elective lower segment CD. They were equally randomized to receive either 1 g of TXA or placebo 15 min before surgery. The primary outcome was Intraoperative blood loss.

Results: The estimated blood loss was significantly higher in the placebo group when compared to TXA group (896.81 ± 519.6 vs. 583.23 ± 379.62 ml, P < 0.001). Both postoperative hemoglobin and hematocrit were lower (9.2 ± 1.6 and 27.4 ± 4.1 vs. 10.1 ± 1.2 and 30.1 ± 3.4, P values < 0.001and 0.012 respectively) and their change percentages (15.41 vs. 7.11%, P < 0.001) were higher in the placebo group when compared to TXA one. The need for further ecbolics was higher in placebo group when compared to TXA group (46.25 vs. 13.75%, P < 0.001).

Conclusion: Preoperative TXA is safe and effective in reducing blood loss during and after high-risk CD.

Trial registration: ClincalTrial.gov ID: NCT03820206 .

Keywords: Elective CS; High risk CS; Intraoperative blood loss; Postpartum hemorrhage; Tranexamic acid.

PubMed Disclaimer

Conflict of interest statement

All authors report that there is no competing interests in this work.

Figures

Fig. 1
Fig. 1
Consort flow chart

References

    1. Jauniaux E, Berghella V. The modern caesarean section. In: Jauniaux E, Grobman WA, editors. Textbook of Caesarean Section. 1. Great Clarendon Street, Oxford, OX2 6DP: Oxford University Press 2016; 2016. pp. 49–68.
    1. Villar J, Carroli G, Zavaleta N, et al. Maternal and neonatal individual risks and benefits associated with caesarean delivery: multicentre prospective study. BMJ. 2007;335:1025. doi: 10.1136/bmj.39363.706956.55. - DOI - PMC - PubMed
    1. Hawkins JL, Chang J, Palmer SK, et al. Anesthesia-related maternal mortality in the United States: 1979–2002. Obstet Gynecol. 2011;117(1):69. doi: 10.1097/AOG.0b013e31820093a9. - DOI - PubMed
    1. De Greve M, Van Mieghem T, Van Den Berghe G, et al. Obstetric admissions to the intensive care unit in a tertiary hospital. Gynecol Obstet Investig. 2016;81(4):315. doi: 10.1159/000431224. - DOI - PubMed
    1. Maged AM, Fawzi T, Shalaby MA, Samy A, Rabee MA, Ali AS, Hussein EA, Hammad B, Deeb WS. A randomized controlled trial of the safety and efficacy of preoperative rectal misoprostol for prevention of intraoperative and postoperative blood loss at elective cesarean delivery. Int J Gynecol Obstet. 2019;147:102–107. doi: 10.1002/ijgo.12922. - DOI - PubMed

Publication types

Associated data